Thomas Baumert
Thomas Baumert
Verified email at
Cited by
Cited by
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
J Lupberger, MB Zeisel, F Xiao, C Thumann, I Fofana, L Zona, C Davis, ...
Nature medicine 17 (5), 589-595, 2011
A human liver cell atlas reveals heterogeneity and epithelial progenitors
N Aizarani, A Saviano, null Sagar, L Mailly, S Durand, JS Herman, ...
Nature 572 (7768), 199-204, 2019
Liver fibrosis: mechanistic concepts and therapeutic perspectives
N Roehlen, E Crouchet, TF Baumert
Cells 9 (4), 875, 2020
Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate
H Barth, C Schäfer, MI Adah, F Zhang, RJ Linhardt, H Toyoda, ...
Journal of Biological Chemistry 278 (42), 41003-41012, 2003
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
JM Pestka, MB Zeisel, E Bläser, P Schürmann, B Bartosch, FL Cosset, ...
Proceedings of the National Academy of Sciences 104 (14), 6025-6030, 2007
miR-122–a key factor and therapeutic target in liver disease
S Bandiera, S Pfeffer, TF Baumert, MB Zeisel
Journal of hepatology 62 (2), 448-457, 2015
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7. 5 cells
V Ramakrishnaiah, C Thumann, I Fofana, F Habersetzer, Q Pan, ...
Proceedings of the National Academy of Sciences 110 (32), 13109-13113, 2013
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells
TF Baumert, S Ito, DT Wong, TJ Liang
Journal of virology 72 (5), 3827-3836, 1998
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81
MB Zeisel, G Koutsoudakis, EK Schnober, A Haberstroh, HE Blum, ...
Hepatology 46 (6), 1722-1731, 2007
Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I
SB Kapadia, H Barth, T Baumert, JA McKeating, FV Chisari
Journal of virology 81 (1), 374-383, 2007
Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission
CL Brimacombe, J Grove, LW Meredith, K Hu, AJ Syder, MV Flores, ...
Journal of virology 85 (1), 596-605, 2011
Curing chronic hepatitis C—the arc of a medical triumph
RT Chung, TF Baumert
New England Journal of Medicine 370 (17), 1576-1578, 2014
Pathogenesis of hepatitis B virus infection
TF Baumert, R Thimme, F von Weizsäcker
World journal of gastroenterology: WJG 13 (1), 82, 2007
Hepatitis C virus infects the endothelial cells of the blood-brain barrier
NF Fletcher, GK Wilson, J Murray, K Hu, A Lewis, GM Reynolds, ...
Gastroenterology 142 (3), 634-643. e6, 2012
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes
D Bankwitz, E Steinmann, J Bitzegeio, S Ciesek, M Friesland, E Herrmann, ...
Journal of virology 84 (11), 5751-5763, 2010
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfateInteraction
H Barth, EK Schnober, F Zhang, RJ Linhardt, E Depla, B Boson, ...
Journal of virology 80 (21), 10579-10590, 2006
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles
WJA Benga, SE Krieger, M Dimitrova, MB Zeisel, M Parnot, J Lupberger, ...
Hepatology 51 (1), 43-53, 2010
Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution
C Neumann‐Haefelin, S McKiernan, S Ward, S Viazov, HC Spangenberg, ...
Hepatology 43 (3), 563-572, 2006
Tight junction proteins in gastrointestinal and liver disease
MB Zeisel, P Dhawan, TF Baumert
Gut 68 (3), 547-561, 2019
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation
X Forns, M Charlton, J Denning, JG McHutchison, WT Symonds, ...
Hepatology 61 (5), 1485-1494, 2015
The system can't perform the operation now. Try again later.
Articles 1–20